Northern Trust’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Northern Trust’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39,414	Closed	-$3.54K	–	4637
2023 Q3	$3.54K	Hold	39,414	–	–	﹤0.01%	4450
2023 Q2	$3.63K	Hold	39,414	–	–	﹤0.01%	4519
2023 Q1	$10.2K	Hold	39,414	–	–	﹤0.01%	4522
2022 Q4	$8.28K	Hold	39,414	–	–	﹤0.01%	4591
2022 Q3	$10K	Hold	39,414	–	–	﹤0.01%	4647
2022 Q2	$28K	Hold	39,414	–	–	﹤0.01%	4572
2022 Q1	$31K	Hold	39,414	–	–	﹤0.01%	4615
2021 Q4	$39K	Hold	39,414	–	–	﹤0.01%	4633
2021 Q3	$69K	Hold	39,414	–	–	﹤0.01%	4481
2021 Q2	$72K	Hold	39,414	–	–	﹤0.01%	4427
2021 Q1	$80K	Buy	39,414 +601	+2%	+$1.41K	﹤0.01%	4322
2020 Q4	$83K	Buy	38,813 +2,822	+8%	+$6.65K	﹤0.01%	4151
2020 Q3	$97K	Sell	35,991 -9,803	-21%	-$35.2K	﹤0.01%	3973
2020 Q2	$180K	Buy	45,794 +23,843	+109%	+$45.6K	﹤0.01%	3788
2020 Q1	$16K	Hold	21,951	–	–	﹤0.01%	4117
2019 Q4	$27K	Buy	21,951 +9,717	+79%	+$8.39K	﹤0.01%	4130
2019 Q3	$8K	Hold	12,234	–	–	﹤0.01%	4201
2019 Q2	$8K	Sell	12,234 -4	-0%	-$8	﹤0.01%	4220
2019 Q1	$34K	Hold	12,238	–	–	﹤0.01%	4080
2018 Q4	$26K	Hold	12,238	–	–	﹤0.01%	4130
2018 Q3	$57K	Hold	12,238	–	–	﹤0.01%	4120
2018 Q2	$56K	Hold	12,238	–	–	﹤0.01%	4112
2018 Q1	$88K	Hold	12,238	–	–	﹤0.01%	4001
2017 Q4	$87K	Hold	12,238	–	–	﹤0.01%	3999
2017 Q3	$102K	Hold	12,238	–	–	﹤0.01%	3949
2017 Q2	$124K	Sell	12,238 -6	-0%	-$59	﹤0.01%	3923
2017 Q1	$141K	Buy	12,244 +1,016	+9%	+$11.5K	﹤0.01%	3883
2016 Q4	$143K	Buy	11,228 +421	+4%	+$6.68K	﹤0.01%	3829
2016 Q3	$198K	Sell	10,807 -25	-0.2%	-$316	﹤0.01%	3735
2016 Q2	$115K	Sell	10,832 -66,443	-86%	-$1.31M	﹤0.01%	3861
2016 Q1	$1.46M	Sell	77,275 -64	-0.1%	-$1.23K	﹤0.01%	3124
2015 Q4	$2.06M	Buy	77,339 +1,618	+2%	+$56.2K	﹤0.01%	3048
2015 Q3	$3.45M	Buy	75,721 +718	+1%	+$27.1K	﹤0.01%	2697
2015 Q2	$2.42M	Sell	75,003 -2,976	-4%	-$86.5K	﹤0.01%	2968
2015 Q1	$2.48M	Buy	77,979 +3,148	+4%	+$107K	﹤0.01%	2999
2014 Q4	$2.83M	Sell	74,831 -4,287	-5%	-$118K	﹤0.01%	2876
2014 Q3	$2.09M	Buy	79,118 +9,257	+13%	+$245K	﹤0.01%	3073
2014 Q2	$2.07M	Sell	69,861 -6,057	-8%	-$196K	﹤0.01%	3077
2014 Q1	$2.81M	Sell	75,918 -8,163	-10%	-$310K	﹤0.01%	2932
2013 Q4	$3.48M	Buy	84,081 +881	+1%	+$34.5K	﹤0.01%	2797
2013 Q3	$4.41M	Buy	83,200 +4,781	+6%	+$279K	﹤0.01%	2590
2013 Q2	$4.19M	Buy	+78,419	New	+$3.92M	﹤0.01%	2540

Other funds holding NAVB

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Northern Trust's NAVB Position: Q4 2023 in Review

Northern Trust sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 39,414 shares — an estimated $3.54K sold.

Northern Trust first reported a position in NAVB in Q2 2013 and held it in 42 quarters. The position peaked at $4.41M in Q3 2013. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

Northern Trust reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 39,414 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $3.54K.
Northern Trust first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 42 quarters.
Northern Trust's Navidea Biopharmaceuticals Inc. position peaked at $4.41M in Q3 2013.
4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.